Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Submissions that are surgical in nature are not in scope for this section and should be submitted to the Surgical Oncology Section of Frontiers in Oncology. Case Reports should include correlative data and expand the current knowledge on the pathophysiological and clinical manifestations of cancer while discussing the cellular and …Background aims: The field of cell and gene therapy in oncology has moved rapidly since 2017 when the first cell and gene therapies, Kymriah followed by Yescarta, were … Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections. 1 Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China; 2 School of Life Science, University of Chinese Academy of Sciences, Beijing, China; 3 Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China; 4 Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China; 5 …Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024, About.markus brunner. Medical University of Vienna. Vienna, Austria. Associate Editor. Head and Neck Cancer. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...To support this goal, the NCI outlined seven areas for research and outreach activities : (1) define the catchment area (i.e. select the area and describe the demographics, special populations, and cancer burden); (2) assess the needs of the catchment area (i.e., basic, clinical, and population science research is conducted to address the ...Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections.Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ...See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.penelope jayne duerksen-hughes. Loma Linda University. Loma Linda, United States. Associate Editor. Gynecological Oncology. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.Perhaps key for incorporation of TDM in oncology, are barriers aligned with knowledge . As evidence to support TDM in oncology is largely provided by academic initiatives, the body of literature is affected by factors such as limited funding and time, and may be the reason for a paucity of clinical studies.Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, …Introduction. Indeed, publications concerning radiomic technique for oncology keep increasing over the past decade. In their valuable article, Ding et al. conducted a bibliometric analysis on the field of radiomics in oncology, with the aim of informing beginners and encouraging more researchers to participate in practicing …» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing … Our ultimate goal is to provide a mechanism of communication between clinicians and researchers that will stimulate and promote a continuation of the multimodal strategies characteristic of the genitourinary oncology field. This section welcomes contributions related to both clinical and basic research findings in the various genitourinary ... Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Jul 4, 2022 · 1 Cancer Research Center for Health Equity, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 2 Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States Scope. The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, …Safeguarding peer review to ensure quality at scale. Making scientific research open has never been more important. But for research to be trusted, it must be of the highest quality. Facing an industry-wide rise in fraudulent science, Frontiers has increased its focus on safeguarding quality. PRESS RELEASE.Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use innovative ...The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access. Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing on advancements in information in cancer biology. ann chen. University of Houston. Houston, United States. Associate Editor. Cancer Epidemiology and Prevention. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of …Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections.Nov 25, 2022 ... Frontiers of Medical Research: Cancer ... Share: ... This Booklet is brought to you by the Science /AAAS Custom Publishing Office. Download PDF.Frontier Airlines is a popular low-cost carrier that offers affordable flights to various destinations across the United States. If you are planning to fly with Frontier, it’s impo...Feb 28, 2023 ... In an initial trial, patients who were in remission after previously having cancer were vaccinated, with the goal of preventing recurrence. Now, ...Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, ranking among the top journals in the category of oncology.32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024 conference from the 27 April – 28 April 2024 to get to the latest advancements in liver and bile duct cancers.A recent retrospective analysis on 152 advanced OSCC patients examined the outcome of cancer therapy and the incidence of tumor recurrence after PBM (660 nm, 40 mW, 10 J/cm 2) for the prevention of OM. Results showed that prophylactic PBM did not influence treatment outcome of primary cancer, recurrence, the development of new primary tumors ...Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or ...In 2019, in Italy, 53,000 new cases of breast cancer have been reported, representing the most commonly diagnosed cancer in women: it can be estimated that …They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …Sep 5, 2022 ... We're addressing the challenge of immune evasion from two angles. Firstly, by finding novel ways to overcome the defensive mechanisms that ...The Cancer Genetics specialty section will facilitate the publication of high-quality original research and review articles pertaining to the genetic, genomic and molecular aspects of cancer, and technical advances that facilitate progress in this field. Focused primarily on molecular genetic aberrations driving malignant processes in human ...How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.Frontiers | Registration - Frontiers | Peer Reviewed ArticlesIn this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...116. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat oncology biology physics (1995) 31(5):1341–6. doi: 10.1016/0360-3016(95)00060-C. CrossRef Full Text | Google ScholarHepatobiliary Surgeons; Colorectal Surgeons; Transplant Surgeons; Medical Oncologists; Radiation Oncologists; Interventional Radiologists; Radiation Therapists ...Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use …Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Frontiers in Oncology publishes high-quality research on all aspects of cancer, from basic science to clinical applications. It has a fast and rigorous peer review process, a high impact factor and cite score, and a large network of editors and reviewers.Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.ISSN 2234-943X (Online) | Frontiers in oncology. Skip to main content. Leave this field blank . Log In; Automatic login IP; PUBLISHERS' AREA DISCOVER ISSN SERVICES SEARCH OPEN ACCESS RESOURCES KEEPERS ... Frontiers. CLOCKSS Archive. 2011. 2024. 10/05/2024. 1 to 14. Preserved. Scholars Portal. 02/05/2024. Preserved : …Aims and scope. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis ...Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.Jul 6, 2018 · The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access. The Cardio-Oncology section of Frontiers in Cardiovascular Medicine is to provide a prime publication platform for this emerging field in medicine. It should speak to clinicians and researchers across the multiple diciplines that contribute to this field, including cardiology, oncology, hematology, radiation oncology, surgery, internal medicine, pediatrics, …Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.3 days ago · bipul r acharya. Cedars Sinai Medical Center. Los Angeles, United States. Associate Editor. Molecular and Cellular Oncology. Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...PCNSTCL with isolated brain involvement occurred in two of 1,040 patients (0.19%). Out of 11 patients with CNS and systemic disease at presentation, brain involvement was documented in four patients, isolated leptomeningeal disease was diagnosed in four patients, combined parenchymal and leptomeningeal disease was detected in two …3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. The radiomics model generated an AUC of 0.722 ( Figure 6C) and 0.706 ( Figure 6D) for HER2 and Ki-67 in the validation cohort, respectively, which was slightly lower than those for ER and PR. Those results suggest that all four models are effective in predicting the molecular expression of BC. In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were
Learn about the different article types that you can submit to Frontiers in Oncology, a peer-reviewed open access journal. Find out the word count, figure limit, fee policy, and format requirements for each article type. They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.Frontiers in Oncology. doi 10.3389/fonc.2024.1370059. 249 views Original Research. Published on 26 Apr 2024 Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis. in Radiation Oncology. Simon K. B. Spohn;francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.Frontier Airlines is a popular choice for travelers looking for affordable flights. With its low-cost fares, the airline has gained a reputation for offering budget-friendly option...Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different disciplines. Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing on advancements in information in cancer biology.4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. Updates on Radiation-induced Lymphopenia. Peter Sylvain Nicolas van Rossum. Steven H Lin. Jian-Yue Jin. 14,906 views. 9 articles. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing … Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.Background aims: The field of cell and gene therapy in oncology has moved rapidly since 2017 when the first cell and gene therapies, Kymriah followed by Yescarta, were …Explore the impact and performance of Frontiers in Oncology, a leading open access journal in the field of cancer research. Find out the number of citations, articles, views, …Frontiers articles are indexed in a number of major international digital archives and repositories, such as PubMed Central, DOAJ, Google Scholar, Chemical Abstracts Service. For additional details on specific indexing, please see the individual journals’ About page.Jing Yang. Xin Li. Rong-Xia Huang. Jian Chen. Frontiers in Oncology. doi 10.3389/fonc.2024.1377486. 161 views. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Immune Cell Exhaustion: New Challenges and Opportunities in Cancer Therapy. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.Currently, the main strategies in cancer immunotherapy include tumor vaccines, adoptive cellular immunotherapy (ACI), and immune checkpoint blockade (ICB) therapy ( 19 – 21 ). However, immune drugs alone are not effective for all patients. Drug resistance or adverse effects, including skin rashes, itching, diarrhea, pneumonia, and thyroid ...Further, Artificial Intelligence and Machine Learning (ML) techniques are also being interlaced with omics strategies to shed light on these molecular mechanisms and provide insight into the genetic and molecular abnormalities that are at play in oral cancer.ML strategies enhance the opportunities to discover novel predictive models for …Frontiers articles are indexed in a number of major international digital archives and repositories, such as PubMed Central, DOAJ, Google Scholar, Chemical Abstracts Service. For additional details on specific indexing, please see the individual journals’ About page.For those who are new to Frontier, logging in to your account can be a bit confusing. Fortunately, the process is actually quite simple and straightforward. The first step is to cr...4 days ago · Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies. Frontiers Breast cancer: miRNAs monitoring chemoresistance and systemic therapy. Shivam Singh 1 Heena Saini 2 Ashok Sharma 3 Subhash Gupta 1 V. G. Huddar 4 Richa Tripathi 2*. 1 Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.Frontiers in Immuno-Oncology. Print Special Issue Flyer. Special Issue Editors. Special Issue Information. Keywords. Published Papers. A special issue of …Dec 21, 2023 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ... This section on Pharmacology of Anti-Cancer Drugs is devoted to the publication of high quality research concerning all aspects of cancer and benign neoplasm drug treatment. The scope of the specialty section encompasses studies related to drugs targeting tumor cells, but also the various components of the tumor microenvironment, including non ... timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.Frontiers in Oncology is composed of the following specialties: Cancer Endocrinology . Cancer Epidemiology and Prevention . Cancer Genetics . Cancer Imaging and Diagnosis …Are you looking for a way to access your Frontier account? With the right steps, you can easily get access to your account and manage your services. Here are the simple steps you n...New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.Scope. This section aims to publish significant clinical and basic research findings on all aspects related to hematologic malignancies, including the areas of acute and chronic leukemias, lymphomas and Hodgkin’s disease, plasma cell disorders, and stem cell transplantation. Our ultimate goal is to accelerate the communication in the field ...Scope. The Urologic Oncology section of Frontiers in Urology publishes high-quality fundamental clinical and translational research, as well as, in-depth reviews across the field of urologic oncology. This section covers the areas including, but not limited to: - Renal cell carcinoma and other renal pathology. - Prostate cancer. - Bladder cancer.Frontiers' open access policy ensures high visibility and maximum exposure of your work - anyone can read your Frontiers articles, without paying any access or subscription costs. Your work can be shared under the terms of the Creative Commons Attribution License. Frontiers submits all its journals for archiving in PubMed Central and PubMed ...Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.Scope. The field of radiation oncology is currently entering a new frontier of more personalized cancer treatment. We are being led into this new frontier by the explosion of information in cancer biology. From the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery, and the refinement of ...The International Cardio-Oncology Society registry shows 21 countries with national cardio-oncology programs, and 81% of centers are in upper-middle to high-income countries . A study of oncologists in the central US showed 67.5% practiced in exclusively urban locations, 11.3% in exclusively rural locations, and 21.1% in both rural and urban …The inherent properties of nanobodies make them advantageous for cancer applications ().Their nanoscale dimensions enable deep penetration of tumors, with certain nanobodies able to cross the blood brain barrier (BBB) ().Nanobodies also retain high affinity and specificity for their target antigens, with low off-target accumulation due to … harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associat